News

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...
Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 diabetes.
Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and ...
The global drug discovery platforms market size is calculated at USD 211.26 million in 2025 and is expected to reach around ...
Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.